
SL Science Holding Ltd
SLBTHealthcare|Biotechnology|US
$0.94
+0.04 (+4.16%)
Ownership Breakdown
40.5%
Float
560.8M
Shares Outstanding
226.9M
Float Shares
Major Holders (3)
Combined: 119.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (13)
Last 4 quarters: 4,545,306 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Hung Chin-Sheng | director, officer: Chief Medical Officer | Nov 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Shen Ethan PhD | Nov 1, 2026 | OTHER | 0 | — | — | Form 4 | |
| Wang Ching-Dong | director, 10 percent owner, officer: Chief Executive Officer | Sep 29, 2026 | BUY | 4,545,306 | $0.50 | $2.3M | Form 4 |
| LAU JOHNSON SHUN-PONG | Aug 31, 2026 | OTHER | 0 | — | — | Form 4 | |
| Wang Ching-Dong | director, 10 percent owner, officer: Chief Executive Officer | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Xu Qian | director | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| LAU JOHNSON SHUN-PONG | officer | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Shen Ethan PhD | director, officer: Chief Technology Officer | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Liu Mingche | director: | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Chen Kwo-Liang | director: | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| General John Conrad | director: | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Leung Lok Sang | officer | Jun 12, 2026 | OTHER | 0 | — | — | Form 4 |
| Levinson Joseph | director: | Jun 15, 2026 | OTHER | 0 | — | — | Form 4 |